“…2) During a pandemic, in communities not yet affected, universally vaccinate with a safe and effective strain-specifi c infl uenza vaccine, if available. 3) During local epidemics, treat all serious clinical cases with an antibacterial agent that is effective against S. pneumoniae, S. pyogenes, H. infl uenzae, and S. aureus (including methicillin-resistant S. aureus); isolate patients with clinical cases from other patients and as many others as possible (35,(37)(38)(39). 4) Conduct pandemic-related surveillance that tracks the incidence, nature (e.g., species, affected sites, antimicrobial drug sensitivities), and outcomes of bacterial infections that complicate infl uenza cases.…”